Refine by MP, party, committee, province, or result type.
Industry committee I'll first of all respond to Mr. Harrison's question, which I wasn't able to respond to before. The sole purpose for filing a U.S. provisional as a first step for an inventor is simply to establish a priority date. It's the formal application that is actually driven by market s
October 4th, 2012Committee meeting
Gail Garland
Industry committee The point about a terminal disclaimer is that this is possible in the U.S. and not possible in Canada. One of the Canadian inventors who belongs to my organization files his patents in the U.S. because he can make use of this terminal disclaimer opportunity. It allows him to co
October 4th, 2012Committee meeting
Gail Garland
Industry committee If I could answer—
October 4th, 2012Committee meeting
Gail Garland
Industry committee An online searchable database, in my view, is just a quick win to help companies that are going through the patent filing process, so that they can keep track of how their application is proceeding through the system and what the deadlines are and so on. It's just an opportunity
October 4th, 2012Committee meeting
Gail Garland
Industry committee Sure. My lens is always what is going to create the greatest commercial opportunity for companies that are inventing, developing, and patenting their technologies here. An indigenous company developing a therapeutic here needs to have the longest period of market exclusivity they
October 4th, 2012Committee meeting
Gail Garland
Industry committee The perspective I bring to this argument is that Canada must match global standards for intellectual property protection if technology is to be invented here, patented here, and commercialized here. My consideration is for the net benefit to our economy of having companies, wheth
October 4th, 2012Committee meeting
Gail Garland
Industry committee I'm sorry, I thought it was for him.
October 4th, 2012Committee meeting
Gail Garland
Industry committee In that case, could I ask you to rephrase the question for me?
October 4th, 2012Committee meeting
Gail Garland
Industry committee I would ask for clarification about what kind of investment you're referring to.
October 4th, 2012Committee meeting
Gail Garland
Industry committee I'm not here on behalf of the multinational pharmaceutical industry, but Canada is a small market. We want to have access to the latest technologies. If our patent regime delivers the right qualities of being predictable, stable, flexible, and consistent, then companies will be
October 4th, 2012Committee meeting
Gail Garland
Industry committee My view would be that a flexible intellectual property system in Canada is important to protect inventions and encourage inventors. Predictability is important because investors, multinationals, people looking to commercialize technologies here, need to know they will have market
October 4th, 2012Committee meeting
Gail Garland
Industry committee There's a point in time element to the argument that's to be made. The IP regimes around the world are moving towards more harmonization. All patents are global from the perspective of a company looking to global markets to commercialize their technology. Our opportunities to be
October 4th, 2012Committee meeting
Gail Garland
Industry committee Our view in the human health technology and bioscience industry is that the role of intellectual property is to protect inventions and encourage inventors so that we can commercialize technology here and allow companies to stay here and grow here. Then we as Canadians can reap th
October 4th, 2012Committee meeting
Gail Garland
Industry committee I should inform you that I'm not a lawyer, so my reference to it was simply to make a point. I'm not qualified to comment on double patenting.
October 4th, 2012Committee meeting
Gail Garland
Industry committee Yes.
October 4th, 2012Committee meeting
Gail Garland